Filter results
You can narrow down the results using the filters
Health topics
Conditions and diseases
Year
Our work
9317 results
-
0.50
COVID-19 vaccination – Is the vaccine safe? (video for young people aged 12 to 17 years)
A COVID-19 vaccination animation, explaining the safety of the COVID-19 vaccines for young people aged 12 to 17 years. -
Coronavirus (COVID-19): National Health Plan resources
A collection of resources for the general public, health professionals and industry outlining a range of funding measures the Australian Government is taking to combat coronavirus (COVID-19). -
Inappropriate practice resource collection
This collection provides information about what inappropriate practice is, how it is identified, why it is important to conduct compliance on inappropriate practice, and commonly found compliance issues -
Key updates for Aboriginal and Torres Strait Islander communities – 23 January 2023
This newsletter provides key health updates for Aboriginal and Torres Strait Islander households, communities and stakeholders. -
Commencement of new prescribed pattern of services – 30/20 telephone rule
Information on the new prescribed pattern of service 30/20 telephone rule, including relevant telephone attendance services. From 1 October 2022, GPs, Other Medical Practitioners and consultant physicians that claim relevant Medicare telephone items will be subject to the new rule. -
Final migration of missing CHSP clients – FAQs
This document answers some frequently asked questions the department has received from Commonwealth Home Support Programme (CHSP) service providers about Missing CHSP Client Migration process. -
Japanese encephalitis virus infection – Surveillance case definition
This document contains the surveillance case definition for Japanese encephalitis virus infection, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
CDBS – Substantiating dental services provided under the schedule
This guideline can help you to substantiate Child Dental Benefits Schedule (CDBS) services that you have claimed or that have been claimed through your provider number. You must also show that consent to dental services and costs has been obtained and recorded. -
COVID-19 and vaccines – Key health updates for Aboriginal and Torres Strait Islander communities
A collection of newsletters sent out to subscribers featuring COVID-19 and vaccines updates and other health updates for Aboriginal and Torres Strait Islander communities. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type I (MPS I)
A collection of resources for health professionals to help people with mucopolysaccharidosis type I (MPS I) access laronidase (Aldurazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Fabry disease
A collection of resources for health professionals to help people with Fabry disease access the following drugs under the Life Saving Drugs Program: agalsidase alfa (Replagal®), agalsidase beta (Fabrazyme®) and migalastat (Galafold®). -
Life Saving Drugs Program – Fabry disease – Review summary and expert panel recommendations
This Fabry disease review considered the two enzyme replacement therapies (ERTs), agalsidase alfa and agalsidase beta. The Expert Panel considered this review at its October 2020 meeting. These documents provide a summary of the review findings and recommendations. -
Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations for consumers
This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers. -
Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations
This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations. -
Life Saving Drugs Program – Fabry disease – Review summary and expert panel recommendations for consumers
This Fabry disease review considered the two enzyme replacement therapies (ERTs), agalsidase alfa and agalsidase beta. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumer -
Exposure draft and explanatory statement – Aged Care Legislation Amendment (Governance and Reporting for Approved Providers) Principles 2022
This is an exposure draft of the proposed amendments to the Accountability Principles 2014 and Records Principles 2014 and the explanatory statement for these amendments. These amendments will support better provider governance and reporting arrangements. -
HS DAG communique – November 2022
An update from the Aboriginal and Torres Strait Islander Health Services Data Advisory Group (HS DAG) following their meeting in October 2022. It outlines the group's work across the Indigenous health data space. -
Commonwealth Home Support Programme (CHSP) Service Catalogue
This chart shows the types of services provided as part of the Commonwealth Home Support Programme (CHSP). -
COVID-19 outbreaks in Australian residential aged care facilities – 20 January 2023
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
COVID-19 vaccination – When to get your COVID-19 vaccination (Aboriginal and Torres Strait Islander people)
This infographic explains when you can get your COVID-19 vaccination. -
COVID-19 vaccination – vaccination data – 20 January 2023
This data file contains statistical data about Australia's COVID-19 vaccinations. -
COVID-19 vaccine rollout update – 20 January 2023
This presentation, delivered on 20 January 2023, contains an update to Australia's COVID-19 vaccine rollout. -
CHSP provider fact sheet 2023–2024 extension
Following the October Budget, the Commonwealth Home Support Programme (CHSP) has been extended until 30 June 2024. This fact sheet outlines what providers need to know about the 2023-24 Extension and associated program changes. -
Commonwealth Home Support Programme (CHSP) Manual
This 2022–2023 manual provides an overview of the Commonwealth Home Support Programme (CHSP), including the service types it funds and requirements for delivering those services. It is for CHSP-funded service providers to use, and forms part of their CHSP grant agreement. -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports
This collection contains the National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports. These reports provide a fortnightly summary on notifications of Australia’s nationally notifiable disease.